Harald Reinhart
Corporate Officer/Principal chez ZAI LAB LIMITED
Fortune : 85 380 $ au 31/03/2024
Profil
Harald Reinhart is currently the President & Head-Global Development at Zai Lab Ltd.
He previously worked as a Senior Vice President at Shionogi, Inc. He holds a doctorate degree from Julius-Maximilians-Universität Würzburg.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ZAI LAB LTD.
0,01% | 04/04/2024 | 51 800 ( 0,01% ) | 85 380 $ | 31/03/2024 |
Postes actifs de Harald Reinhart
Sociétés | Poste | Début |
---|---|---|
ZAI LAB LIMITED | Corporate Officer/Principal | 01/01/2017 |
Anciens postes connus de Harald Reinhart
Sociétés | Poste | Fin |
---|---|---|
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the private company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019. | Corporate Officer/Principal | - |
Formation de Harald Reinhart
Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ZAI LAB LIMITED | Health Technology |
Entreprise privées | 1 |
---|---|
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the private company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019. | Health Technology |